SynthesisMedicine2016

EGFR-TKIs versus taxanes agents in therapy for nonsmall-cell lung cancer patients: A PRISMA-compliant systematic review with meta-analysis and meta-regression.

Na An et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.